FDA approves Akebia anemia pill, two years after rejection
BioPharma
Source: biopharmadive.com
Stay updated with breaking news from Dive Brief. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The startup’s performance will test investors’ appetite for early-stage drugmakers, as Boundless has only advanced as far as Phase 1 clinical trials.
Construction industry news, trends and jobs for building professionals who want mobile-friendly content.
The company hired Jay Rooney as chief financial officer as it focuses on growing its buffet concept while overall unit count shrinks.